{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:10:13Z","timestamp":1785208213560,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009539","name":"International Life Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016659","name":"International Life Sciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004747","name":"Amway Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007082","name":"Pharmavite LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.advnut.2026.100623","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:14:23Z","timestamp":1774487663000},"page":"100623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Framework for Developing Intake and Use Guidance for Dietary Supplement Bioactives"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-886X","authenticated-orcid":false,"given":"Janet A","family":"Novotny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario G","family":"Ferruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Gurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasija","family":"Karosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.advnut.2026.100623_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1460-9","article-title":"Optimal nutrition and the ever-changing dietary landscape: a conference report","volume":"56","author":"Shao","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib2","series-title":"Public Law No. 103-417 Stat. 4325","year":"1994"},{"key":"10.1016\/j.advnut.2026.100623_bib3","first-page":"1","article-title":"Dietary supplement use among adults: United States, 2017-2018","volume":"399","author":"Mishra","year":"2021","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.advnut.2026.100623_bib4","series-title":"2023 consumer survey on dietary supplements","year":"2023"},{"key":"10.1016\/j.advnut.2026.100623_bib5","first-page":"1","article-title":"Clinically relevant herb-drug interactions: a 30-year historical assessment","volume":"22","author":"Gurley","year":"2024","journal-title":"J. Diet. Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.advnut.2026.100623_bib6","first-page":"1","article-title":"Exploring the benefits and challenges of establishing a DRI-like process for bioactives","volume":"53","author":"Lupton","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib7","series-title":"Guiding principles for developing dietary Reference Intakes based on chronic disease","year":"2017"},{"issue":"1","key":"10.1016\/j.advnut.2026.100623_bib8","doi-asserted-by":"crossref","first-page":"249S","DOI":"10.3945\/ajcn.116.139097","article-title":"Options for basing dietary reference intakes (DRIs) on chronic disease endpoints: report from a joint US\/Canadian-sponsored working group","volume":"105","author":"Yetley","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.advnut.2026.100623_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ajcn\/nqy293","article-title":"A report of activities related to the Dietary Reference Intakes from the Joint Canada-US Dietary Reference Intakes Working Group","volume":"109","author":"MacFarlane","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.advnut.2026.100623_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/advances\/nmab044","article-title":"Perspective: framework for developing recommended intakes of bioactive dietary substances","volume":"12","author":"Yates","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101103","article-title":"Have safety and efficacy assessments of bioactives come of age?","volume":"89","author":"Dwyer","year":"2023","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.advnut.2026.100623_bib12","series-title":"Federal Register Vol. 69 No. 179 FR Doc 04-20892","first-page":"55821","article-title":"Solicitation of written comments on proposed definition of bioactive food components","year":"2004"},{"issue":"1","key":"10.1016\/j.advnut.2026.100623_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1096\/fj.201902143R","article-title":"Improving natural products research translation: from source to clinical trial","volume":"34","author":"Sorkin","year":"2020","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.advnut.2026.100623_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26040","article-title":"Analysis of select dietary supplement products marketed to support or boost the immune system","volume":"5","author":"Crawford","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.advnut.2026.100623_bib15","unstructured":"U.S. Food and Drug Administration, Policy Regarding Quantitative Labeling of Dietary Supplements Containing Live Microbials: Draft Guidance for Industry. 83 Fed. Reg. 45454-45455, Docket No. FDA-2018-D-3464 (2018). [Cited January 2025] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/draft-guidance-industry-policy-regarding-quantitative-labeling-dietary-supplements-containing-live"},{"key":"10.1016\/j.advnut.2026.100623_bib16","series-title":"Best Practices for Probiotics [Internet]","year":"2020"},{"issue":"6","key":"10.1016\/j.advnut.2026.100623_bib17","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.xphs.2020.02.005","article-title":"Disintegration and dissolution testing of green tea dietary supplements: application and evaluation of United States Pharmacopeial standards","volume":"109","author":"Gusev","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.advnut.2026.100623_bib18","first-page":"36","article-title":"Alteration in dissolution characteristics of gelatin-containing formulations","volume":"43","author":"Singh","year":"2002","journal-title":"Pharma. Technol."},{"issue":"2","key":"10.1016\/j.advnut.2026.100623_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/pharmaceutics13020214","article-title":"Challenges of dissolution methods development for soft gelatin capsules","volume":"13","author":"Damian","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.advnut.2026.100623_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/ajcn\/70.5.826","article-title":"Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans","volume":"70","author":"Ostlund","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/nutrit\/nuz081","article-title":"Terms and nomenclature used for plant-derived components in nutrition and related research: efforts toward harmonization","volume":"78","author":"Frank","year":"2020","journal-title":"Nutr. Rev."},{"issue":"5 Suppl","key":"10.1016\/j.advnut.2026.100623_bib22","first-page":"208","article-title":"An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda, Afr. J. Tradit. Complement","volume":"8","author":"Singh","year":"2011","journal-title":"Altern. Med."},{"issue":"6","key":"10.1016\/j.advnut.2026.100623_bib23","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ajcn\/84.6.1430","article-title":"A feasibility study quantifying in vivo human alpha-tocopherol metabolism","volume":"84","author":"Clifford","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"issue":"18","key":"10.1016\/j.advnut.2026.100623_bib24","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/jf4005862","article-title":"Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States","volume":"61","author":"Wang","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.advnut.2026.100623_bib25","series-title":"DRI Dietary Reference Intakes: Applications in Dietary Assessment","year":"2000"},{"key":"10.1016\/j.advnut.2026.100623_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yrtph.2017.01.002","article-title":"Bioactive nutrients - Time for tolerable upper intake levels to address safety","volume":"84","author":"Yates","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"10","key":"10.1016\/j.advnut.2026.100623_bib27","doi-asserted-by":"crossref","first-page":"1992S","DOI":"10.1093\/jn\/138.10.1992S","article-title":"Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substances","volume":"138","author":"Hathcock","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib28","unstructured":"Joint FAO\/WHO Technical Workshop on Food Nutrient Risk Assessment (2005 : Geneva, Switzerland), World Health Organization, Food and Agriculture Organization of the United Nations & International Programme on Chemical Safety (2006). A model for establishing upper levels of intake for nutrients and related substances : report of a Joint FAO\/WHO Technical Workshop on Food Nutrient Risk Assessment, WHO Headquarters, Geneva, Switzerland, 2-6 May 2005. World Health Organization. World Health Organization. (2006) [Cited January 2025] Available from: https:\/\/iris.who.int\/handle\/10665\/43451"},{"issue":"1","key":"10.1016\/j.advnut.2026.100623_bib29","first-page":"115","article-title":"Highest observed intake: definition, regulatory uses and provisional values","volume":"61","author":"Hathcock","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.advnut.2026.100623_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heha.2025.100129","article-title":"Assessment of heavy metals pollution in vegetables grown on irrigated soil and their potential threat to human health and global food security","volume":"14","author":"Manegabe","year":"2025","journal-title":"Hygiene Environ. Health Adv"},{"issue":"sup1","key":"10.1016\/j.advnut.2026.100623_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/10715762.2019.1636045","article-title":"Contaminants: a dark side of food supplements?","volume":"53","author":"Costa","year":"2019","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.advnut.2026.100623_bib32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1039\/D4NP00014E","article-title":"Estimating the extend of adulteration of the popular herbs black cohosh, echinacea, elderberry, ginkgo, and tumeric \u2013 its challenges and limitations","volume":"14","author":"Orhan","year":"2024","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.advnut.2026.100623_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.105513","article-title":"Low-cost analytic method for the identification of Cinnamon adulteration","volume":"159","author":"Cantarelli","year":"2020","journal-title":"Microchem. J."},{"issue":"8","key":"10.1016\/j.advnut.2026.100623_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jcph.2046","article-title":"Continued risk of dietary supplements adulterated with approved and unapproved drugs: assessment of the US Food and Drug Administration\u2019s Tainted Supplements Database 2007 through 2021","volume":"62","author":"White","year":"2022","journal-title":"J. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.advnut.2026.100623_bib35","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.3390\/molecules26226903","article-title":"Adulteration of weight loss supplements by the illegal addition of synthetic pharmaceuticals","volume":"26","author":"Jairoun","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.advnut.2026.100623_bib36","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1039\/D4FO01113A","article-title":"Nutraceuticals and dietary supplements: balancing out the pros and cons","volume":"15","author":"Fernandes","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.advnut.2026.100623_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/464921","article-title":"Oxidation of marine omega-3 supplements and human health","volume":"2013","author":"Albert","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.advnut.2026.100623_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302250","article-title":"Shell formulation in soft gelatin capsules: design and characterization","volume":"13","author":"Naharros-Molinero","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.advnut.2026.100623_bib39","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/nu11040776","article-title":"Decaffeinated green tea extract does not elicit hepatotoxic effects and modulates the gut microbiome in lean B6C3F(1) mice","volume":"11","author":"Gurley","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100623_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/cdn\/nzaa045_052","article-title":"Green tea extract as a safe and effective dietary supplement: lessons learned from mice","volume":"4","author":"Kortubash","year":"2020","journal-title":"Curr. Dev. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.advnut.2026.100623_bib42","doi-asserted-by":"crossref","first-page":"524S","DOI":"10.1093\/advances\/nmy029","article-title":"Clinically relevant herb-micronutrient interactions: when botanicals, minerals, and vitamins collide","volume":"9","author":"Gurley","year":"2018","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.advnut.2026.100623_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcn\/73.3.607","article-title":"Green tea or rosemary extract added to foods reduces nonheme-iron absorption","volume":"73","author":"Samman","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.advnut.2026.100623_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12011-012-9448-z","article-title":"Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients","volume":"149","author":"Suliburska","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"issue":"6","key":"10.1016\/j.advnut.2026.100623_bib45","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/bph.14936","article-title":"Clinical relevance of St. John\u2019s wort drug interactions revisited","volume":"177","author":"Nicolussi","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.advnut.2026.100623_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archsurg.137.3.316","article-title":"St John\u2019s Wort supplements endanger the success of organ transplantation","volume":"137","author":"Ernst","year":"2002","journal-title":"Arch. Surg."},{"issue":"6","key":"10.1016\/j.advnut.2026.100623_bib47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.contraception.2016.07.010","article-title":"Co-administration of St. John\u2019s wort and hormonal contraceptives: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"issue":"13","key":"10.1016\/j.advnut.2026.100623_bib48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1055\/s-0031-1298331","article-title":"Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med."},{"issue":"13","key":"10.1016\/j.advnut.2026.100623_bib49","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1055\/s-0031-1298273","article-title":"Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements","volume":"78","author":"Gurley","year":"2012","journal-title":"Planta Med"},{"key":"10.1016\/j.advnut.2026.100623_bib50","unstructured":"Food & Drug Administration. FDA raises concerns about probiotic products sold for use in hospitalized preterm infants. (2023) [Cited November 2024] Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants (2023)."},{"key":"10.1016\/j.advnut.2026.100623_bib51","series-title":"What is pharmacovigilance?","year":"2026"},{"key":"10.1016\/j.advnut.2026.100623_bib52","doi-asserted-by":"crossref","DOI":"10.2196\/57824","article-title":"Applying AI to structured real-world data for pharmacovigilance purposes: scoping review","volume":"26","author":"Dimitsaki","year":"2024","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.advnut.2026.100623_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221143272","article-title":"Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review","volume":"14","author":"Makhene","year":"2023","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.advnut.2026.100623_bib54","article-title":"Designing a clinical study with dietary supplements: it\u2019s all in the details","volume":"8","author":"Floyd","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.advnut.2026.100623_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4155\/ipk-2016-0009","article-title":"Practical considerations when designing and conducting clinical pharmacokinetic herb\u2013drug interaction studies","volume":"2","author":"Gurley","year":"2017","journal-title":"Int. J. Pharmacokinet."},{"key":"10.1016\/j.advnut.2026.100623_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115822","article-title":"Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters","volume":"301","author":"Husain","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.advnut.2026.100623_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1632941","article-title":"Advancing human health risk assessment: the role of new approach methodologies","volume":"7","author":"Deepika","year":"2025","journal-title":"Front. Toxicol."},{"issue":"4","key":"10.1016\/j.advnut.2026.100623_bib58","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14732","article-title":"Low-density lipoprotein receptor is required for cholesteryl ester transfer protein to regulate triglyceride metabolism in both male and female mice","volume":"9","author":"Palmisano","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.advnut.2026.100623_bib59","article-title":"Progress in developing rodent models of age-related macular degeneraton (AMD)","volume":"203","author":"Pandi","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.advnut.2026.100623_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1404938","article-title":"Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4","volume":"15","author":"Albadry","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.advnut.2026.100623_bib61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.31989\/ffhd.v7i5.345","article-title":"Allometric scaling models: history, use, and misuse in translating resveratrol from basic science to human clinical applications","volume":"7","author":"Smoliga","year":"2017","journal-title":"Funct. Foods Health Dis"},{"key":"10.1016\/j.advnut.2026.100623_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ptr.4966","article-title":"Animal studies on medicinal herb: predictability, dose conversion, and potential value","volume":"28","author":"Wojcikowski","year":"2013","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.advnut.2026.100623_bib63","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cmet.2017.04.033","article-title":"A guide for the design of pre-clinical studies on sex differences in metabolism","volume":"25","author":"Mauvais-Jarvis","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.advnut.2026.100623_bib64","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.fct.2017.08.021","article-title":"Medicinal properties of mangosteen (L.): a comprehensive update","volume":"109","author":"Ovalle-Magallanes","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.advnut.2026.100623_bib65","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/fft2.369","article-title":"Human-based new approach methodologies to accelerate advances in nutrition research","volume":"5","author":"Cassota","year":"2024","journal-title":"Food Front"},{"key":"10.1016\/j.advnut.2026.100623_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"10.1016\/j.advnut.2026.100623_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2021.101375","article-title":"From Arksey and O'Malley and beyond: customizations to enhance a team-based, mixed approach to scoping review methodology","volume":"8","author":"Westphaln","year":"2021","journal-title":"MethodsX"},{"issue":"12 Pt 2","key":"10.1016\/j.advnut.2026.100623_bib68","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00009","article-title":"Challenges in systematic reviews that assess treatment harms","volume":"142","author":"Chou","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.advnut.2026.100623_bib69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jclinepi.2021.10.023","article-title":"Harms in systematic reviews, paper 1: an introduction to research on harms","volume":"143","author":"Qureshi","year":"2022","journal-title":"J. Clin. Epidemiol."}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831326000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831326000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:23:31Z","timestamp":1783034611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831326000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2161831326000372"],"URL":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100623","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Framework for Developing Intake and Use Guidance for Dietary Supplement Bioactives","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"100623"}}